NCT00552461View on ClinicalTrials.gov

Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

December 31, 2011

Conditions

Pulmonary Alveolar ProteinosisPrimary Disease

Interventions

DRUG

rituximab

IV, 1000 mg, two weeks, 2 times

Trial Locations (1)

27834

East Carolina University, Greenville

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

East Carolina University

OTHER

NCT00552461 - Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis | Biotech Hunter | Biotech Hunter